Importance of Sox2 in maintenance of cell proliferation and multipotency of mesenchymal stem cells in low-density culture

Cell Proliferation

Volumn 44, Issue 5, 2011, Pages 428-440

  Yoon, D S ^a,b   Kim, Y H ^b   Jung, H S ^b   Paik, S ^a,b   Lee, J W ^a,b  

^a Yonsei University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; TRANSCRIPTION FACTOR DLX5; TRANSCRIPTION FACTOR MSX2; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SOX2;

ADULT; AGED; ARTICLE; BONE MARROW; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IN VITRO STUDY; MALE; MESENCHYMAL STEM CELL; NORMAL HUMAN; PROTEIN EXPRESSION; RNA INTERFERENCE; SPINDLE CELL;

BASE SEQUENCE; CELL COUNT; CELL CULTURE TECHNIQUES; CELL CYCLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELLS, CULTURED; COLONY-FORMING UNITS ASSAY; DNA PRIMERS; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; GENETIC MARKERS; HOMEODOMAIN PROTEINS; HUMANS; MULTIPOTENT STEM CELLS; OSTEOGENESIS; PHENOTYPE; RNA INTERFERENCE; RNA, MESSENGER; SOXB1 TRANSCRIPTION FACTORS;

EID: 80053168047     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2011.00770.x     Document Type: Article

References (55)

1. Kuznetsov SA, Krebsbach PH, Satomura K, Kerr J, Riminucci M, Benayahu D et al. (1997) Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo. J. Bone Miner. Res. 12, 1335-1347.
2. Jaiswal N, Haynesworth SE, Caplan AI, Bruder SP (1997) Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J. Cell. Biochem. 64, 295-312.
3. Haynesworth SE, Goshima J, Goldberg VM, Caplan AI (1992) Characterization of cells with osteogenic potential from human marrow. Bone 13, 81-88.
4. Johnstone B, Hering TM, Caplan AI, Goldberg VM, Yoo JU (1998) In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp. Cell Res. 238, 265-272.
5. Yoo JU, Barthel TS, Nishimura K, Solchaga L, Caplan AI, Goldberg VM et al. (1998) The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells. J. Bone Joint Surg. Am. 80, 1745-1757.
6. Wang WG, Lou SQ, Ju XD, Xia K, Xia JH (2003) In vitro chondrogenesis of human bone marrow-derived mesenchymal progenitor cells in monolayer culture: activation by transfection with TGF-beta2. Tissue Cell 35, 69-77.
7. Neubauer M, Hacker M, Bauer-Kreisel P, Weiser B, Fischbach C, Schulz MB et al. (2005) Adipose tissue engineering based on mesenchymal stem cells and basic fibroblast growth factor in vitro. Tissue Eng. 11, 1840-1851.
8. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR et al. (2002) Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418, 41-49.
9. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284, 143-147.
10. Prockop DJ (1997) Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276, 71-74.
11. Conget PA, Minguell JJ (1999) Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J. Cell. Physiol. 181, 67-73.
12. Lazarus HM, Haynesworth SE, Gerson SL, Rosenthal NS, Caplan AI (1995) Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. Bone Marrow Transplant. 16, 557-564.
13. Minguell JJ, Erices A, Conget P (2001) Mesenchymal stem cells. Exp. Biol. Med. (Maywood) 226, 507-520.
14. Mets T, Verdonk G (1981) In vitro aging of human bone marrow derived stromal cells. Mech. Ageing Dev. 16, 81-89.
15. Bruder SP, Jaiswal N, Haynesworth SE (1997) Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J. Cell. Biochem. 64, 278-294.
16. Digirolamo CM, Stokes D, Colter D, Phinney DG, Class R, Prockop DJ (1999) Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. Br. J. Haematol. 107, 275-281.
17. Rombouts WJ, Ploemacher RE (2003) Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture. Leukemia 17, 160-170.
18. Baxter MA, Wynn RF, Jowitt SN, Wraith JE, Fairbairn LJ, Bellantuono I (2004) Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. Stem Cells 22, 675-682.
19. Ksiazek K (2009) A comprehensive review on mesenchymal stem cell growth and senescence. Rejuvenation Res. 12, 105-116.
20. Hayflick L (1965) The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 37, 614-636.
21. Dennis JE, Carbillet JP, Caplan AI, Charbord P (2002) The STRO-1+ marrow cell population is multipotential. Cells Tissues Organs 170, 73-82.
22. Prockop DJ, Sekiya I, Colter DC (2001) Isolation and characterization of rapidly self-renewing stem cells from cultures of human marrow stromal cells. Cytotherapy 3, 393-396.
23. Stolzing A, Jones E, McGonagle D, Scutt A (2008) Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies. Mech. Ageing Dev. 129, 163-173.
24. Nishida S, Endo N, Yamagiwa H, Tanizawa T, Takahashi HE (1999) Number of osteoprogenitor cells in human bone marrow markedly decreases after skeletal maturation. J. Bone Miner. Metab. 17, 171-177.
25. van den Bos C, Silverstetter S, Murphy M, Connolly T (1998) p21(cip1) rescues human mesenchymal stem cells from apoptosis induced by low-density culture. Cell Tissue Res. 293, 463-470.
26. Sekiya I, Larson BL, Smith JR, Pochampally R, Cui JG, Prockop DJ (2002) Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells 20, 530-541.
27. Neuhuber B, Swanger SA, Howard L, Mackay A, Fischer I (2008) Effects of plating density and culture time on bone marrow stromal cell characteristics. Exp. Hematol. 36, 1176-1185.
28. Chen L, Tredget EE, Wu PY, Wu Y (2008) Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One 3, e1886.
29. Mueller MB, Tuan RS (2008) Functional characterization of hypertrophy in chondrogenesis of human mesenchymal stem cells. Arthritis Rheum. 58, 1377-1388.
30. Dickhut A, Pelttari K, Janicki P, Wagner W, Eckstein V, Egermann M et al. (2009) Calcification or dedifferentiation: requirement to lock mesenchymal stem cells in a desired differentiation stage. J. Cell. Physiol. 219, 219-226.
31. Goessler UR, Bieback K, Bugert P, Heller T, Sadick H, Hormann K et al. (2006) In vitro analysis of integrin expression during chondrogenic differentiation of mesenchymal stem cells and chondrocytes upon dedifferentiation in cell culture. Int. J. Mol. Med. 17, 301-307.
32. Wagner W, Bork S, Horn P, Krunic D, Walenda T, Diehlmann A et al. (2009) Aging and replicative senescence have related effects on human stem and progenitor cells. PLoS One 4, e5846.
33. Pierantozzi E, Gava B, Manini I, Roviello F, Marotta G, Chiavarelli M et al. (2010) Pluripotency regulators in human mesenchymal stem cells: expression of NANOG but not of OCT-4 and SOX-2. Stem Cells Dev. 20, 915-923.
34. Izadpanah R, Trygg C, Patel B, Kriedt C, Dufour J, Gimble JM et al. (2006) Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue. J. Cell. Biochem. 99, 1285-1297.
35. Go MJ, Takenaka C, Ohgushi H (2008) Forced expression of Sox2 or Nanog in human bone marrow derived mesenchymal stem cells maintains their expansion and differentiation capabilities. Exp. Cell Res. 314, 1147-1154.
36. Colter DC, Class R, DiGirolamo CM, Prockop DJ (2000) Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc. Natl. Acad. Sci. USA 97, 3213-3218.
37. Kozhevnikova MN, Mikaelian AS, Paiushina OV, Starostin VI (2008) Comparative characterization of mesenchymal bone marrow stromal cells at early and late stages of culturing. Izv. Akad. Nauk Ser. Biol. 2, 156-162.
38. Banfi A, Muraglia A, Dozin B, Mastrogiacomo M, Cancedda R, Quarto R (2000) Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: implications for their use in cell therapy. Exp. Hematol. 28, 707-715.
39. Wang Q, Hirohashi Y, Furuuchi K, Zhao H, Liu Q, Zhang H et al. (2004) The centrosome in normal and transformed cells. DNA Cell Biol. 23, 475-489.
40. Marzec M, Kasprzycka M, Lai R, Gladden AB, Wlodarski P, Tomczak E et al. (2006) Mantle cell lymphoma cells express predominantly cyclin D1a isoform and are highly sensitive to selective inhibition of CDK4 kinase activity. Blood 108, 1744-1750.
41. Sciortino S, Gurtner A, Manni I, Fontemaggi G, Dey A, Sacchi A et al. (2001) The cyclin B1 gene is actively transcribed during mitosis in HeLa cells. EMBO Rep. 2, 1018-1023.
42. Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676.
43. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K et al. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872.
44. Shi W, Wang H, Pan G, Geng Y, Guo Y, Pei D (2006) Regulation of the pluripotency marker Rex-1 by Nanog and Sox2. J. Biol. Chem. 281, 23319-23325.
45. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S et al. (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920.
46. Lengner CJ, Camargo FD, Hochedlinger K, Welstead GG, Zaidi S, Gokhale S et al. (2007) Oct4 expression is not required for mouse somatic stem cell self-renewal. Cell Stem Cell 1, 403-415.
47. Basu-Roy U, Ambrosetti D, Favaro R, Nicolis SK, Mansukhani A, Basilico C (2010) The transcription factor Sox2 is required for osteoblast self-renewal. Cell Death Differ. 17, 1345-1353.
48. Liu TM, Wu YN, Guo XM, Hui JH, Lee EH, Lim B (2009) Effects of ectopic Nanog and Oct4 overexpression on mesenchymal stem cells. Stem Cells Dev. 18, 1013-1022.
49. Wagner W, Horn P, Castoldi M, Diehlmann A, Bork S, Saffrich R et al. (2008) Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS One 3, e2213.
50. Satokata I, Ma L, Ohshima H, Bei M, Woo I, Nishizawa K et al. (2000) Msx2 deficiency in mice causes pleiotropic defects in bone growth and ectodermal organ formation. Nat. Genet. 24, 391-395.
51. Liu YH, Tang Z, Kundu RK, Wu L, Luo W, Zhu D et al. (1999) Msx2 gene dosage influences the number of proliferative osteogenic cells in growth centers of the developing murine skull: a possible mechanism for MSX2-mediated craniosynostosis in humans. Dev. Biol. 205, 260-274.
52. Ishii M, Merrill AE, Chan YS, Gitelman I, Rice DP, Sucov HM et al. (2003) Msx2 and Twist cooperatively control the development of the neural crest-derived skeletogenic mesenchyme of the murine skull vault. Development 130, 6131-6142.
53. Ichida F, Nishimura R, Hata K, Matsubara T, Ikeda F, Hisada K et al. (2004) Reciprocal roles of MSX2 in regulation of osteoblast and adipocyte differentiation. J. Biol. Chem. 279, 34015-34022.
54. Dodig M, Tadic T, Kronenberg MS, Dacic S, Liu YH, Maxson R et al. (1999) Ectopic Msx2 overexpression inhibits and Msx2 antisense stimulates calvarial osteoblast differentiation. Dev. Biol. 209, 298-307.
55. Mina M, Gluhak J, Rodgers B (1996) Downregulation of Msx-2 expression results in chondrogenesis in the medial region of the avian mandible. Connect. Tissue Res. 35, 79-84.